...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Article
7
Oct 25, 2020 10:06AM

This article pretty well maps out BOM2:

Apabetalone decreased the risk of major cardiovascular events (MACE) and hospitalization for congestive heart failure compared with placebo among patients with diabetic CKD and recent acute coronary syndrome.

Giddy Up Don!

 

Koo

 

4
Oct 25, 2020 12:45PM
2
Oct 25, 2020 01:02PM
1
Oct 25, 2020 01:54PM
5
Oct 25, 2020 06:20PM
Share
New Message
Please login to post a reply